October 31, 2012 at 12:40 PM EDT
Exelixis, Celgene, Gilead Sciences, Dynavax See Key Dates in November
MINYANVILLE ORIGINAL Pharma and biotech investors can expect a number of stock catalysts in November including Food and Drug Administration advisory panels and a first peak at scientific abstracts for a major medical meeting in December. The following is a list of some highlights for the month. As always a number of dates are subject to change. November 1 Hurricane Sandy prompted some companies including Pfizer (NYSE:PFE) Onyx Pharmaceuticals (NASDAQ:ONXX) and Vertex Pharmaceuticals (NASDAQ:VRTX) to delay reporting quarterly results until Thursday. Vertex and Onyx plan to release results after markets while Pfizer is expected to report in the ...
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here